{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T14:43:20Z","timestamp":1778856200264,"version":"3.51.4"},"reference-count":42,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ajkd.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Kidney Diseases"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1053\/j.ajkd.2023.08.016","type":"journal-article","created":{"date-parts":[[2023,10,12]],"date-time":"2023-10-12T21:48:04Z","timestamp":1697147284000},"page":"477-488","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Association of Stroke With Metabolic Dysfunction\u2013Associated Fatty Liver Disease With and Without CKD"],"prefix":"10.1053","volume":"83","author":[{"given":"Yuhao","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shouling","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingli","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yijun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yingting","family":"Zuo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xue","family":"Tian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuohua","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aijun","family":"Xing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anxin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6496-8016","authenticated-orcid":false,"given":"Yan","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"10","key":"10.1053\/j.ajkd.2023.08.016_bib1","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/S1474-4422(21)00252-0","article-title":"GBD 2019 Stroke Collaborators. Global, regional, and national burden of stroke and its risk factors, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019","volume":"20","year":"2021","journal-title":"Lancet Neurol"},{"issue":"12","key":"10.1053\/j.ajkd.2023.08.016_bib2","doi-asserted-by":"crossref","first-page":"e897","DOI":"10.1016\/S2468-2667(21)00228-0","article-title":"Temporal trend and attributable risk factors of stroke burden in China, 1990-2019: an analysis for the Global Burden of Disease Study 2019","volume":"6","author":"Ma","year":"2021","journal-title":"Lancet Public Health"},{"issue":"10225","key":"10.1053\/j.ajkd.2023.08.016_bib3","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/S0140-6736(20)30045-3","article-title":"Global, regional, and national burden of chronic kidney disease, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017","volume":"395","year":"2020","journal-title":"Lancet"},{"issue":"10","key":"10.1053\/j.ajkd.2023.08.016_bib4","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1177\/0271678X19866733","article-title":"Chronic kidney disease in the pathogenesis of acute ischemic stroke","volume":"39","author":"Chelluboina","year":"2019","journal-title":"J\u00a0Cereb Blood Flow Metab"},{"issue":"3","key":"10.1053\/j.ajkd.2023.08.016_bib5","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1053\/j.ajkd.2020.09.015","article-title":"Kidney function as risk factor and predictor of cardiovascular outcomes and mortality among older adults","volume":"77","author":"K\u00fchn","year":"2021","journal-title":"Am J Kidney Dis"},{"issue":"2","key":"10.1053\/j.ajkd.2023.08.016_bib6","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.kint.2019.09.024","article-title":"Prevention and treatment of stroke in patients with chronic kidney disease: an overview of evidence and current guidelines","volume":"97","author":"Kelly","year":"2020","journal-title":"Kidney Int"},{"issue":"suppl","key":"10.1053\/j.ajkd.2023.08.016_bib7","doi-asserted-by":"crossref","first-page":"S302","DOI":"10.3350\/cmh.2022.0329","article-title":"Non-alcoholic fatty liver disease: the pathologist\u2019s perspective","volume":"29","author":"Leow","year":"2023","journal-title":"Clin Mol Hepatol"},{"issue":"1","key":"10.1053\/j.ajkd.2023.08.016_bib8","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1161\/STROKEAHA.120.030433","article-title":"Severity of nonalcoholic fatty liver disease and risk of future ischemic stroke events","volume":"52","author":"Xu","year":"2021","journal-title":"Stroke"},{"issue":"1 suppl","key":"10.1053\/j.ajkd.2023.08.016_bib9","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.1016\/j.jhep.2014.12.012","article-title":"NAFLD: a multisystem disease","volume":"62","author":"Byrne","year":"2015","journal-title":"J\u00a0Hepatol"},{"issue":"1","key":"10.1053\/j.ajkd.2023.08.016_bib10","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.jhep.2020.03.039","article-title":"A\u00a0new definition for metabolic dysfunction-associated fatty liver disease: an international expert consensus statement","volume":"73","author":"Eslam","year":"2020","journal-title":"J\u00a0Hepatol"},{"key":"10.1053\/j.ajkd.2023.08.016_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2019.104617","article-title":"The gut-liver-kidney axis: novel regulator of fatty liver associated chronic kidney disease","volume":"152","author":"Raj","year":"2020","journal-title":"Pharmacol Res"},{"issue":"1","key":"10.1053\/j.ajkd.2023.08.016_bib12","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1186\/s12872-018-0877-2","article-title":"Association between nonalcoholic fatty liver disease and subclinical atherosclerosis: a cross-sectional study on population over 40 years old","volume":"18","author":"Zheng","year":"2018","journal-title":"BMC Cardiovasc Disord"},{"issue":"11","key":"10.1053\/j.ajkd.2023.08.016_bib13","doi-asserted-by":"crossref","first-page":"825","DOI":"10.7326\/0003-4819-158-11-201306040-00007","article-title":"Improving Global Outcomes Chronic Kidney Disease Guideline Development Work Group Members. Evaluation and management of chronic kidney disease: synopsis of the kidney disease: improving global outcomes 2012 clinical practice guideline","volume":"158","author":"Stevens","year":"2013","journal-title":"Ann Intern Med"},{"issue":"7","key":"10.1053\/j.ajkd.2023.08.016_bib14","doi-asserted-by":"crossref","first-page":"3347","DOI":"10.1210\/jc.2010-0288","article-title":"The product of triglycerides and glucose, a simple measure of insulin sensitivity: comparison with the euglycemic-hyperinsulinemic clamp","volume":"95","author":"Guerrero-Romero","year":"2010","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"10","key":"10.1053\/j.ajkd.2023.08.016_bib15","article-title":"Association of normal serum uric acid level and cardiovascular disease in people without risk factors for cardiac diseases in China","volume":"12","author":"Tian","year":"2023","journal-title":"J\u00a0Am Heart Assoc"},{"issue":"1","key":"10.1053\/j.ajkd.2023.08.016_bib16","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1186\/s12933-022-01577-7","article-title":"Triglyceride-glucose index trajectory and stroke incidence in patients with hypertension: a prospective cohort study","volume":"21","author":"Huang","year":"2022","journal-title":"Cardiovasc Diabetol"},{"issue":"10","key":"10.1053\/j.ajkd.2023.08.016_bib17","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1161\/01.STR.20.10.1407","article-title":"Stroke\u20141989. Recommendations on stroke prevention, diagnosis, and therapy. Report of the WHO Task Force on Stroke and other Cerebrovascular Disorders","volume":"20","year":"1989","journal-title":"Stroke"},{"issue":"2","key":"10.1053\/j.ajkd.2023.08.016_bib18","doi-asserted-by":"crossref","first-page":"e745","DOI":"10.1210\/clinem\/dgab644","article-title":"Metabolic dysfunction-associated fatty liver disease and mortality among chinese adults: a prospective cohort study","volume":"107","author":"Wang","year":"2022","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"1","key":"10.1053\/j.ajkd.2023.08.016_bib19","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1186\/s12916-022-02413-1","article-title":"Elevated levels of body mass index and waist circumference, but not high variability, are associated with an increased risk of atrial fibrillation","volume":"20","author":"Zhao","year":"2022","journal-title":"BMC Med"},{"issue":"20","key":"10.1053\/j.ajkd.2023.08.016_bib20","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1001\/jama.2019.17725","article-title":"Association of baclofen with encephalopathy in patients with chronic kidney disease","volume":"322","author":"Muanda","year":"2019","journal-title":"JAMA"},{"issue":"10","key":"10.1053\/j.ajkd.2023.08.016_bib21","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.1016\/j.cgh.2020.12.022","article-title":"Metabolic dysfunction-associated fatty liver disease and incident cardiovascular disease risk: a nationwide cohort study","volume":"19","author":"Lee","year":"2021","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"1","key":"10.1053\/j.ajkd.2023.08.016_bib22","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1210\/clinem\/dgab641","article-title":"Association of MAFLD with diabetes, chronic kidney disease, and cardiovascular disease: a 4.6-year cohort study in China","volume":"107","author":"Liang","year":"2022","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"6","key":"10.1053\/j.ajkd.2023.08.016_bib23","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1016\/j.jhep.2021.07.035","article-title":"Metabolic dysfunction-associated fatty liver disease is associated with increased all-cause mortality in the United States","volume":"75","author":"Kim","year":"2021","journal-title":"J\u00a0Hepatol"},{"issue":"9675","key":"10.1053\/j.ajkd.2023.08.016_bib24","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1016\/S0140-6736(09)60371-8","article-title":"Intracerebral haemorrhage","volume":"373","author":"Qureshi","year":"2009","journal-title":"Lancet"},{"issue":"11","key":"10.1053\/j.ajkd.2023.08.016_bib25","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1001\/jama.2020.26867","article-title":"Diagnosis and management of transient ischemic attack and acute ischemic stroke: a review","volume":"325","author":"Mendelson","year":"2021","journal-title":"JAMA"},{"issue":"9","key":"10.1053\/j.ajkd.2023.08.016_bib26","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1136\/gutjnl-2020-320622","article-title":"NAFLD and increased risk of cardiovascular disease: clinical associations, pathophysiological mechanisms and pharmacological implications","volume":"69","author":"Targher","year":"2020","journal-title":"Gut"},{"issue":"9","key":"10.1053\/j.ajkd.2023.08.016_bib27","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1136\/gutjnl-2021-325724","article-title":"Non-alcoholic fatty liver disease and incident major adverse cardiovascular events: results from a nationwide histology cohort","volume":"71","author":"Simon","year":"2022","journal-title":"Gut"},{"issue":"39","key":"10.1053\/j.ajkd.2023.08.016_bib28","doi-asserted-by":"crossref","first-page":"2948","DOI":"10.1093\/eurheartj\/ehx342","article-title":"Gut microbe-generated metabolite trimethylamine-N-oxide as cardiovascular risk biomarker: a systematic review and dose-response meta-analysis","volume":"38","author":"Schiattarella","year":"2017","journal-title":"Eur Heart J"},{"key":"10.1053\/j.ajkd.2023.08.016_bib29","article-title":"Associations of gut-flora-dependent metabolite trimethylamine-N-oxide, betaine and choline with non-alcoholic fatty liver disease in adults","volume":"6","author":"Chen","year":"2016","journal-title":"Sci Rep"},{"key":"10.1053\/j.ajkd.2023.08.016_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2021.154779","article-title":"The progression and regression of metabolic dysfunction-associated fatty liver disease are associated with the development of subclinical atherosclerosis: a prospective analysis","volume":"120","author":"Liu","year":"2021","journal-title":"Metabolism"},{"issue":"4","key":"10.1053\/j.ajkd.2023.08.016_bib31","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1007\/s12072-022-10362-3","article-title":"A\u00a0new risk stratification strategy for fatty liver disease by incorporating MAFLD and fibrosis score in a large US population","volume":"16","author":"Zhang","year":"2022","journal-title":"Hepatol Int"},{"issue":"5","key":"10.1053\/j.ajkd.2023.08.016_bib32","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1002\/hep.32499","article-title":"Are there outcome differences between NAFLD and metabolic-associated fatty liver disease?","volume":"76","author":"Younossi","year":"2022","journal-title":"Hepatology"},{"key":"10.1053\/j.ajkd.2023.08.016_bib33","article-title":"NAFLD or MAFLD: which has closer association with all-cause and cause-specific mortality? Results from NHANES III","volume":"8","author":"Huang","year":"2021","journal-title":"Front Med"},{"issue":"9","key":"10.1053\/j.ajkd.2023.08.016_bib34","doi-asserted-by":"crossref","first-page":"2670","DOI":"10.1210\/clinem\/dgab339","article-title":"Metabolic dysfunction-associated fatty liver disease (MAFLD)\u2014rather a bystander than a driver of mortality","volume":"106","author":"Semmler","year":"2021","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1053\/j.ajkd.2023.08.016_bib35","doi-asserted-by":"crossref","DOI":"10.2196\/45050","article-title":"The role of metabolic dysfunction-associated fatty liver disease in developing chronic kidney disease: longitudinal cohort study","volume":"9","author":"Wei","year":"2023","journal-title":"JMIR Public Health Surveill"},{"issue":"21","key":"10.1053\/j.ajkd.2023.08.016_bib36","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.201800430","article-title":"Bioengineering organs for blood detoxification","volume":"7","author":"Legallais","year":"2018","journal-title":"Adv Healthc Mater"},{"key":"10.1053\/j.ajkd.2023.08.016_bib37","doi-asserted-by":"crossref","unstructured":"Rinella ME, Lazarus JV, Ratziu V, et\u00a0al. A multi-society Delphi consensus statement on new fatty liver disease nomenclature. J Hepatol. Published online June 24, 2023. doi:10.1016\/j.jhep.2023.06.003","DOI":"10.1097\/HEP.0000000000000696"},{"issue":"6","key":"10.1053\/j.ajkd.2023.08.016_bib38","doi-asserted-by":"crossref","DOI":"10.1111\/ijcp.14131","article-title":"The association of the steatosis severity, NAFLD fibrosis score and FIB-4 index with atherogenic dyslipidaemia in adult patients with NAFLD: a cross-sectional study","volume":"75","author":"Tutunchi","year":"2021","journal-title":"Int J Clin Pract"},{"issue":"6","key":"10.1053\/j.ajkd.2023.08.016_bib39","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1007\/s12072-022-10407-7","article-title":"Long-term cardiovascular outcomes differ across metabolic dysfunction-associated fatty liver disease subtypes among middle-aged population","volume":"16","author":"Lee","year":"2022","journal-title":"Hepatol Int"},{"issue":"4","key":"10.1053\/j.ajkd.2023.08.016_bib40","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/j.jhep.2021.06.013","article-title":"Are the different MAFLD subtypes based on the inclusion criteria correlated with all-cause mortality?","volume":"75","author":"Chen","year":"2021","journal-title":"J\u00a0Hepatol"},{"issue":"3","key":"10.1053\/j.ajkd.2023.08.016_bib41","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1002\/hep.24452","article-title":"Diagnostic accuracy and reliability of ultrasonography for the detection of fatty liver: a meta-analysis","volume":"54","author":"Hernaez","year":"2011","journal-title":"Hepatology"},{"issue":"5","key":"10.1053\/j.ajkd.2023.08.016_bib42","doi-asserted-by":"crossref","first-page":"840","DOI":"10.14309\/ajg.0000000000002020","article-title":"A\u00a0reappraisal of the diagnostic performance of B-mode ultrasonography for mild liver steatosis","volume":"118","author":"Lee","year":"2023","journal-title":"Am J Gastroenterol"}],"container-title":["American Journal of Kidney Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638623008582?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638623008582?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T03:50:21Z","timestamp":1759463421000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0272638623008582"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":42,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["S0272638623008582"],"URL":"https:\/\/doi.org\/10.1053\/j.ajkd.2023.08.016","relation":{},"ISSN":["0272-6386"],"issn-type":[{"value":"0272-6386","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association of Stroke With Metabolic Dysfunction\u2013Associated Fatty Liver Disease With and Without CKD","name":"articletitle","label":"Article Title"},{"value":"American Journal of Kidney Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.ajkd.2023.08.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 by the National Kidney Foundation, Inc.","name":"copyright","label":"Copyright"}]}}